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Protein expression profiling in Plasmodium <p>A quantitative time-course analysis of protein abundance for Plasmodium falciparum schizonts using two-dimensional differential gel  electrophoresis reveals significant post-transcriptional regulation.</p>
Abstract
Background: Malaria is a one of the most important infectious diseases and is caused by parasitic
protozoa of the genus Plasmodium. Previously, quantitative characterization of the P. falciparum
transcriptome demonstrated that the strictly controlled progression of these parasites through
their intra-erythrocytic developmental cycle is accompanied by a continuous cascade of gene
expression. Although such analyses have proven immensely useful, the correlations between
abundance of transcripts and their cognate proteins remain poorly characterized.
Results: Here, we present a quantitative time-course analysis of relative protein abundance for
schizont-stage parasites (34 to 46 hours after invasion) based on two-dimensional differential gel
electrophoresis of protein samples labeled with fluorescent dyes. For this purpose we analyzed
parasite samples taken at 4-hour intervals from a tightly synchronized culture and established more
than 500 individual protein abundance profiles with high temporal resolution and quantitative
reproducibility. Approximately half of all profiles exhibit a significant change in abundance and 12%
display an expression peak during the observed 12-hour time interval. Intriguingly, identification of
54 protein spots by mass spectrometry revealed that 58% of the corresponding proteins - including
actin-I, enolase, eukaryotic initiation factor (eIF)4A, eIF5A, and several heat shock proteins - are
represented by more than one isoform, presumably caused by post-translational modifications,
with the various isoforms of a given protein frequently showing different expression patterns.
Furthermore, comparisons with transcriptome data generated from the same parasite samples
reveal evidence of significant post-transcriptional gene expression regulation.
Conclusions: Together, our data indicate that both post-transcriptional and post-translational
events are widespread and of presumably great biological significance during the intra-erythrocytic
development of P. falciparum.
Published: 17 December 2008
Genome Biology 2008, 9:R177 (doi:10.1186/gb-2008-9-12-r177)
Received: 19 September 2008
Revised: 1 December 2008
Accepted: 17 December 2008
The electronic version of this article is the complete one and can be 
found online at http://genomebiology.com/2008/9/12/R177http://genomebiology.com/2008/9/12/R177 Genome Biology 2008,     Volume 9, Issue 12, Article R177       Foth et al. R177.2
Genome Biology 2008, 9:R177
Background
Malaria is a serious parasitic disease that causes millions of
deaths and incalculable suffering each year. It is caused by
unicellular parasites of the genus Plasmodium that are trans-
mitted between humans by a mosquito vector. A total of five
species of Plasmodium parasites reportedly affect humans
[1], with P. falciparum being by far the deadliest. Plasmo-
dium parasites are characterized by a complex life cycle, dur-
ing which they undergo extensive morphological and
metabolic changes that reflect a robust adaptation of these
parasites to the various host environments and ensure their
growth and transmission.
After the injection of infectious sporozoites into the human
host and an initial round of hepatocyte infection, the para-
sites replicate within red blood cells, progressing through an
intra-erythrocytic developmental cycle (IDC) that takes the
parasites about 48 hours to complete. Based on morphologi-
cal appearance, the IDC has been divided into three develop-
mental stages: ring, trophozoite, and schizont. The invasion
of a red blood cell by a free, extracellular merozoite leads to
the formation of the ring stage that lasts until 16 to 24 hours
post-invasion (HPI). After a period of feeding and growth, the
parasite enters the trophozoite stage (about 16 to 32 HPI),
during which DNA replication begins. After repeated nuclear
divisions, daughter cells are produced within the schizonts
(about 32 to 48 HPI), with the release of multiple free mero-
zoites marking the end of the IDC. This rapid asexual multi-
plication during the Plasmodium IDC causes the trademark
clinical symptoms of the disease, ranging from fever, muscle
aches and anemia, to organ failure, coma and death. The
abundance of the blood-stage parasites and their prolonged
occurrence in the human host render the IDC an important
target of available antimalaria chemotherapies, as well as new
drug-based and vaccine-based intervention strategies that
are being developed.
Recent studies in P. falciparum have shown that morpholog-
ical and metabolic development during the IDC is accompa-
nied by large-scale, tightly controlled changes in gene
transcription [2,3]. According to these transcriptome analy-
ses, the vast majority of genes exhibit a cyclical expression
pattern as the parasites progress through the IDC with a sin-
gle peak in transcript levels. This rolling gene expression cas-
cade was likened to a 'just-in-time' manufacturing process, in
which induction of any given gene occurs at the time (or just
before) it is required and in which the transcript is translated
into its cognate protein without (much) delay. There is a
remarkable conservation and rigidity of the IDC transcrip-
tional cascade among different strains and species of Plasmo-
dium, and genes from the same cellular or metabolic
pathways often share similar profiles of mRNA abundance,
ensuring their efficient function in the context of life cycle
development [4,5].
However, several other studies have indicated that for many
Plasmodium genes post-transcriptional regulation also plays
a significant role in the expression of their protein products
[6-11]. LeRoch and colleagues [6] conducted large-scale com-
parisons of mRNA and protein levels across seven major
developmental stages of the P. falciparum life cycle. Although
moderately high correlations were observed between the
transcriptome and proteome of each stage, a significant frac-
tion of genes were found to exhibit a delay between the peak
abundance of mRNA and protein. In addition, the authors
were able to identify a few consensus motifs in the 5'-untrans-
lated regions that correlated with the transcript-protein accu-
mulation pattern and are potentially involved in post-
transcriptional regulation during the IDC. Another study [7]
demonstrated that up to 370 transcripts that are produced
during the gametocyte stage are translationally repressed
until gamete fertilization via DDX6 RNA helicase-containing
complexes. Relieving translational repression may lead to
apparent translational upregulation, because investigators
[8,9] showed that treatment with antifolate drugs can reduce
the otherwise detectable translational suppression of the pro-
tein target of these drugs. Aiming for a fully quantitative
approach, the same authors utilized two-dimensional gel
electrophoresis with metabolically labeled proteins to charac-
terize protein abundance across the P. falciparum IDC [10].
Again, results of these analyses suggested a widespread
occurrence of post-transcriptional regulation in Plasmodium
parasites. Such post-transcriptional regulation may also
explain several discrepancies between mRNA abundance
profiles and the expected timing of protein activity for several
members of the P. falciparum pentose phosphate and
REDOX metabolic pathways [12,13].
Besides translational control of protein expression, post-
translational modifications (PTMs) have also been shown to
play a critical role in the regulation of protein activity during
the Plasmodium life cycle. These include proteolytic cleavage
[14-18], glycosylation [19,20], phosphorylation [21,22], myr-
istoylation [23], acetylation [24,25], and ubiquitination
[26,27]. For example, the importance of proteolytic cleavage
and glycosylation was established for various surface anti-
gens, many of which are involved in merozoite invasion [14-
16,19]. However, cytoplasmic proteins may also undergo spe-
cific PTMs that affect their enzymatic activities and/or cellu-
lar functions. Kumar and coworkers [17] showed that two P.
falciparum phosphatases (PP7 and PP2B) are proteolytically
truncated, leaving the active core intact. Altough the phos-
phatase activity of the full-length protein is sensitive to cal-
cium concentrations, the processed core exhibits constitutive
activity insensitive to calcium. For Plasmodium enolase, an
essential glycolytic enzyme, at least five post-translationally
modified isoforms have been found. Subcellular fractionation
revealed differential enrichment of the enolase isoforms in
different cellular compartment/fractions, including cytosol,
cytoskeleton, membranes, and nucleus [21].http://genomebiology.com/2008/9/12/R177 Genome Biology 2008,     Volume 9, Issue 12, Article R177       Foth et al. R177.3
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Taken together, these data indicate that translational regula-
tion and PTMs (along with transcription) play a significant
role in the timing of protein activities during the extensive
transformations associated with the Plasmodium life cycle.
However, we still lack a more detailed overview of the extent
of post-transcriptional gene regulation and PTMs during the
IDC, largely because most relevant studies either focused on
particular proteomes (prepared by cell fractionation, after
drug treatment, or from nonerythrocytic life cycle stages),
employed nonquantitative or semiquantitative techniques, or
examined only very broadly defined parasite stages such as
rings, trophozoites, and schizonts (see, for example, refer-
ences [10,11,19,28-31]).
In this study we used two-dimensional differential gel electro-
phoresis (2D-DIGE) [32] in quantitative proteomics analyses
to investigate the extent of post-transcriptional gene regula-
tion and PTMs during the late section of the P. falciparum
IDC. We demonstrate that this technique provides high
reproducibility suitable for quantitative measurements of rel-
ative protein abundance from samples collected at short time
intervals from a highly synchronous P. falciparum culture.
Using this approach we assembled high-resolution protein
abundance profiles (four samples taken at 34, 38, 42, and 46
HPI) for 623 individual proteins/protein isoforms across the
schizont-stage development. Of these, we identified more
than 50 parasite protein isoforms by tandem mass spectrom-
etry (MS/MS) and compared their protein expression profiles
with the corresponding transcript levels observed from the
same cell samples. Our data reveal striking examples of trans-
lational gene regulation and many instances of proteins that
occur in multiple isoforms that are probably due to PTMs
and/or pre-translational events, such as alternative splicing
or transcription initiation/termination. Intriguingly, some
protein isoforms exhibit expression patterns that are clearly
distinct from those of other isoforms representing the same
protein. We thus confirm that post-transcriptional events are
widespread and of presumably great biological significance
for Plasmodium, and that they should not be disregarded if a
comprehensive functional analysis of its proteins is to be
achieved.
Results
Experimental design
2D-DIGE is a technique that allows quantitative measure-
ments of relative abundance of individual proteins in complex
samples [32]. Its key advantage is that - by using the three dif-
ferent fluorescent dyes Cy2, Cy3, and Cy5 - up to three differ-
ent samples can be run simultaneously on one gel and
quantitatively compared with one another. Here, we
employed 2D-DIGE to measure relative protein abundance
profiles in a time-course manner across schizont-stage para-
sites of P. falciparum. We collected parasite samples at 4-
hour intervals at 34, 38, 42, and 46 HPI (referred to as time
point [TP]1 to TP4). We also assembled a protein reference
pool from the protein lysates of the four parasite samples that
was labeled with Cy2 and used as internal standard through-
out the entire study (Table 1). Each individual TP protein
preparation was run in four separate experiments utilizing
first-dimension strips spanning pH 3 to pH 7. To ensure the
fidelity and unbiased character of the protein abundance
measurements, each protein preparation was analyzed using
both Cy3 and Cy5 flourophores in a dye-swap manner, and
the sample loading scheme was designed such that the sam-
ples were assigned randomly to different gels (Table 1). The
ratio between the fluorescence signals of the individual TP
samples (Cy3 or Cy5) and the protein reference pool (Cy2)
was used to assemble relative protein expression profiles (see
below). Figure 1a shows a typical spot pattern of the protein
reference pool resolved by two-dimensional gel electrophore-
sis (gel3, pH3-7NL, Cy2-channel), whereas Figure 1b shows
the corresponding overlay image of the Cy3 (green) and Cy5
(red) signals derived from TP1 and TP3 samples, respectively.
A total of 623 protein spots could be confidently discerned
and matched across the eight gels, with the three-dimen-
sional 'landscape representation' of the two-dimensional gel
images generated by the DeCyder gel analysis software facili-
tating the matching and referencing of all protein spots across
multiple gels (see Figure 2a). Often, more than one spot per
gel was identified as the same protein (see below), and in such
cases we use the term protein 'isoforms' to refer to the multi-
ple protein products of the same gene. Such isoforms usually
originate from PTMs such as phosphorylation, glycosylation,
acetylation, acylation, ubiquination, or limited proteolysis
(see, for example, reference [33]).
Quantitative 2D-DIGE data
To arrive at relative protein abundance measurements using
2D-DIGE, we used the DeCyder software to calculate the raw
background-subtracted volume for each protein spot and
subsequently normalize these values (see Materials and
methods, below, for details). For every spot, we calculated
volume ratios that correspond to the ratio of the normalized
spot volume from an individual protein sample (observed in
the Cy3 or Cy5 channel) over the spot volume of the same spot
from the protein reference pool (Cy2 channel). Given that this
internal standard (Cy2) is identical in all gels, these volume
ratios represent a reliable measure of a protein spot's relative
abundance across multiple gels. In total, we included eight
gels in the analysis that yielded 16 quantitative measurements
for each spot (one observation in the Cy3 and one in the Cy5
channel of each gel). The average of the four measurements
made for each spot per TP sample was thus used to establish
the protein abundance profiles.
Figure 2 panels a to c illustrate this process for five protein
spots that correspond to isoforms of RNA helicase-1, a protein
that is also referred to as P. falciparum helicase 45 (PfH45) or
as eukaryotic initiation factor (eIF)4A [34]. Interestingly, we
observe two clearly distinct types of abundance profiles with
three isoforms (1, 2, and 3), which initially increase in theirhttp://genomebiology.com/2008/9/12/R177 Genome Biology 2008,     Volume 9, Issue 12, Article R177       Foth et al. R177.4
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intensity and level off for the rest of the time course, and two
isoforms (4 and 5) that undergo a significant decrease
through TP1 and TP2 and subsequent recovery in TP3 and
TP4 (Figure 2c). These contrasting trends are also clearly vis-
ible in one gel in which samples from both TP1 (Cy3, green)
and TP2 (Cy5, red) were run together (Figure 2b). The largest
fold change in protein abundance of eIF4A was detected for
isoform 1, which exhibited 3.3-fold increase between TP1 and
TP2. In comparison the maximum fold change detected in the
entire analysis was for one isoform of eIF5A, which exhibited
a 15.1-fold increase throughout the time course (Figure 2d).
To identify all proteins/isoforms whose abundance changes
significantly through the schizont stage, we employed the
one-way analysis of variance (ANOVA), as implemented in
the DeCyder software. We find that a total of 345 proteins/
isoforms exhibit abundance profiles with significantly (P <
0.01) greater variation in the measurements between the TP
samples than within the TP samples. In addition, 278 of these
proteins/isoforms also exhibit a fold change in excess of 1.4×,
which - together with an ANOVA P < 0.01 - we chose as a cri-
terion to delineate those proteins/isoforms whose change in
abundance across the four TPs is more likely to be biologically
significant. Of these, about one quarter (69 isoforms) change
by more than threefold and 9% (24 isoforms) by more than
fivefold (Figure 3a). Classifying these 278 expression profiles
by the direction of their change (Figure 3b; see Materials and
methods, below, for details), we find one-quarter (70 profiles)
to increase steadily ('up'), approximately one-quarter (75 pro-
files) to exhibit an expression peak ('up-down'), and more
than one-third (103 profiles) to decrease consistently ('down')
during schizont development.
Unlike most studies that use 2D-DIGE to identify exclusively
those proteins that are differentially expressed between dif-
ferent samples, we were also interested in the expression pro-
files of proteins/isoforms whose abundance did not change
significantly (ANOVA, P > 0.01) across the four different TP
samples. We therefore employed a second statistical measure
of variation, the relative standard deviation (defined as stand-
ard deviation divided by arithmetic mean), to assess explicitly
the reproducibility of protein abundance measurements. The
relative standard deviation was calculated for each protein
spot for each of the four TP samples, and the median of these
four values was taken as a measure of experimental reproduc-
ibility for that spot (see Figure 2c and Table 2[35]). Compari-
son of these values with the graphical representation of the
raw data (see Additional data file 1) illustrates the spread of
the data. For the 278 proteins/isoforms that do exhibit signif-
icant abundance change across the four TP samples and a fold
change in excess of 1.4×, the average value of their median
relative standard deviations was 11.0%. Interestingly, this
value also corresponds to the shoulder of the bimodal distri-
bution of the median relative standard deviations of those
Representative two-dimensional DIGE gels of P. falciparum schizont-stage proteins Figure 1
Representative two-dimensional DIGE gels of P. falciparum schizont-stage proteins. (a) Protein reference pool (internal standard) labeled with 
Cy2. (b) Overlay of images showing Cy3-labeled and Cy5-labeled parasite proteins from time point (TP) samples 1 (TP1, green) and 3 (TP3, red). Proteins 
were separated in the first dimension along a nonlinear pH gradient (pH3-7NL, 24 cm Immobiline DryStrip [GE Healthcare]), and in the second dimension 
on an 11% polyacrylamide gel. Proteins/protein isoforms identified by tandem mass spectrometry are highlighted in color. In instances where more than 
one spot was identified as the same protein, the spots were numbered in numerical order from left to right (not shown), except for enolase, for which 
spot numbers are denoted in the figure. The molecular weight marker is indicated in kDa. DIGE, differential gel electrophoresis.
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278 proteins/isoforms whose ANOVA result was nonsignifi-
cant (P > 0.01; data not shown). Using this value as a repro-
ducibility threshold, we thus consider the abundance of 183
proteins/isoforms (29%) to exhibit minimal change through
the schizont stage with high experimental confidence, thereby
reflecting constitutive expression of these proteins/isoforms
across the schizont stage. Another 96 proteins/isoforms
(15%) that also do not show a significant change in expression
do at the same time exhibit considerable experimental varia-
tion in the protein measurements (typically due to low signal
levels; see Figure 3b).
To create an overview of global protein abundance dynamics
during the P. falciparum schizont stage, we carried out hier-
archical clustering with the 278 protein abundance profiles
that exhibit a significant ANOVA (P < 0.01) and a fold change
in abundance in excess of 1.4× (Figure 4), with the four panels
in Figure 4 corresponding to the categories already men-
tioned above ('up', 'up-down', 'down', and 'down-up') and
indicated in Figure 3b. These data show, for example, that
most isoforms of the invasion-related molecule actin-I exhibit
an expression peak during late schizont development, as is
expected based on its function [36]. Also, in many cases mul-
tiple isoforms of a given protein vary greatly from one another
Figure 2
(a)
(b)
(c) (d)
Determining relative protein abundance using 2D-DIGE Figure 2
Determining relative protein abundance using 2D-DIGE. The 
relative protein abundance of a spot is defined as the normalized spot 
volume observed in the Cy3 or Cy5 channel (protein from a time point 
sample) divided by the normalized spot volume of the same spot measured 
in the Cy2 channel (protein reference pool) on the same gel. (a) gel 
images and three-dimensional 'landscape representation' of five protein 
spots identified as eukaryotic initiation factor (eIF)4A (or RNA helicase-1/
helicase 45; PF14_0655) of P. falciparum. The top panel ('Pool') shows a 
representative image (gel3; see Table 1) of the Cy2-labeled protein 
reference pool/internal standard, whereas the lower panels depict one 
typical image for each of the four time point (TP) samples (TP1: Cy3/gel3; 
TP2: Cy5/gel7; TP3: Cy3/gel4; TP4: Cy5/gel6). (b) Overlay image of the 
Cy3-labeled and Cy5-labeled eIF4A isoforms from TP1 (green) and TP2 
(red) from gel1. (c) Summary of the quantitative DIGE data and the 
resulting relative protein abundance profiles for the five eIF4A isoforms 
derived from all eight gels. The table presents the corresponding relative 
standard deviations for each set of four abundance measurements (for a 
given spot and time point sample) as well as the median value of the four 
relative standard deviations for each spot. (d) Three-dimensional 
presentation of eIF5A (PFL0210c) isoform 1, which happened to be the 
spot exhibiting the greatest fold change in the entire analysis (15.1-fold 
increase in relative protein abundance between TP1 and TP4). 2D-DIGE, 
two-dimensional differential gel electrophoresis.
Table 1
Gel-loading regimen
Gel TP1 TP2 TP3 TP4 Pool
gel1 Cy3 Cy5 Cy2
gel2 Cy5 Cy3 Cy2
gel3 Cy3 Cy5 Cy2
gel4 Cy5 Cy3 Cy2
gel5 Cy3 Cy5 Cy2
gel6 Cy3 Cy5 Cy2
gel7 Cy5 Cy3 Cy2
gel8 Cy3 Cy5 Cy2
Each two-dimensional gel was loaded with 50 μg of a Cy3-labeled time 
point (TP) sample, 50 μg of a different Cy5-labeled TP sample, and 50 
μg of the Cy2-labeled internal standard (protein reference pool).http://genomebiology.com/2008/9/12/R177 Genome Biology 2008,     Volume 9, Issue 12, Article R177       Foth et al. R177.6
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in their expression pattern (for example, eIF5A). A detailed
analysis and discussion of protein abundance and function is
presented below.
Protein identification
A total of 54 protein spots were excised from two-dimensional
gels and confidently identified by tandem mass spectrometry
(MS/MS) and Mascot searching of the MS/MS data against
GenBank's nr database as well as a custom database contain-
ing Plasmodium and human proteins. For almost all identi-
fied protein spots, Mascot matched three or more individual
peptides yielding a sequence coverage of more than 10% and
a Mascot score (probability-based Mowse score) that is con-
siderably greater (score typically >100) than the significance
threshold (ion score of 35 to 55 for P < 0.05) given by the soft-
ware (Table 2). In addition, the positions of these proteins on
our two-dimensional gels are in good agreement with calcu-
lated masses and pI values (Figure 1 and Table 2) as well as
with previously published data [10,36]. The 54 identified pro-
tein spots were found to derive from a total of 24 parasite and
two human proteins, with 15 of these proteins having been
encountered in more than one protein spot (Figure 1 and
Table 2). The limited scope of identified proteins notwith-
standing, these findings suggest that more than 50% of Plas-
modium proteins might be present in numerous isoforms in
the cell, which are probabaly due to PTMs and/or alternative
pretranslational events. Enolase represents the protein with
the highest number of isoforms (7) detected in this study (Fig-
ure 1).
Protein expression profiles and mRNA levels
For the parasite proteins identified by mass spectrometry, we
then compared the DIGE protein expression profiles with the
following: microarray data that we generated from the same
parasite samples that were used for the proteomic analysis,
and with the previously published P. falciparum IDC tran-
scriptome [2]. The microarray data produced in this study are
in good agreement with the high-resolution IDC transcrip-
tome, confirming the tight synchronization and appropriate
progression of our parasite culture through schizont develop-
ment (Figure 5; see Additional data files 2 to 4). In addition,
the comparisons of the 2D-DIGE data with the transcription
Figure 3
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Statistics of changes in relative protein abundance Figure 3
Statistics of changes in relative protein abundance. (a) Cumulative 
histogram of maximum fold change in relative abundance for proteins/
isoforms that exhibit significant change (analysis of variance [ANOVA] P < 
0.01) throughout the four schizont-stage time point (TP) samples. (b) the 
pie chart on the left illustrates how the 623 differential gel electrophoresis 
(DIGE) protein expression profiles are distributed among four categories 
defined by the statistical measures of variation (ANOVA), experimental 
reproducibility (median relative standard deviation [RelStDev]), and the 
maximum fold change (MFC) of relative protein abundance. The partial pie 
chart on the right provides an additional classification relating to the 
direction of abundance change, with the icons giving a generic illustration 
of each category.h
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Table 2
Protein data for the 54 protein isoforms identified in this study
Protein name PlasmoDB ID and NCBI 
GenBank accession number
Calculated Spot 
number
Mascot MS/MS ion search Average volume ratio Relative standard deviation Maximum 
fold change
One-way 
ANOVA P value
Mass 
(kDa)
pI Score Peptides 
matched
Sequence 
coverage
TP1 TP2 TP3 TP4 TP1 TP2 TP3 TP4 Median
2-Cys peroxiredoxin [PDB:PF14_0368]
[Genbank:AAN36981]
22.0 6.7 - 559 4 48% 1.03 1.02 0.96 0.78 5.3% 15.4% 9.9% 6.4% 8.1% 1.33× 0.016
Actin-I [PDB:PFL2215w]
[Genbank:AAN36527]
42.1 5.2 1 533 9 40% 0.58 0.97 1.30 1.24 5.9% 5.9% 8.5% 3.2% 5.9% 2.24× <0.001
2 609 8 37% 0.60 0.93 1.44 1.25 4.8% 5.6% 5.6% 3.4% 5.2% 2.39× <0.001
3 391 8 36% 0.66 1.01 1.60 1.35 7.0% 4.4% 7.0% 2.2% 5.7% 2.43× <0.001
4 415 5 21% 0.63 0.94 1.21 0.97 7.7% 3.4% 8.6% 6.8% 7.3% 1.91× <0.001
5 192 6 29% 1.57 0.73 0.78 1.40 8.7% 7.0% 12.6% 11.3% 10.0% 2.15× <0.001
Adenosine deaminase [PDB:PF10_0289]
[Genbank:AAN35486]
42.9 5.4 - 484 7 23% 1.24 1.18 1.15 0.80 14.5% 5.0% 2.6% 6.6% 5.8% 1.55× <0.001
eIF4A/RNA helicase-1/helicase 45 [PDB:PF14_0655]
[Genbank:AAN37268]
45.3 5.5 1 318 8 24% 0.41 1.32 1.19 1.01 4.4% 3.7% 7.8% 5.8% 5.1% 3.26× <0.001
2 159 2 10% 0.61 1.24 1.23 1.05 5.6% 5.0% 6.6% 2.7% 5.3% 2.03× <0.001
3 143 6 22% 0.73 1.20 1.30 1.16 8.8% 6.1% 20.6% 9.5% 9.2% 1.79× <0.001
4 133 4 19% 1.58 0.57 0.88 1.11 5.7% 5.2% 8.2% 3.6% 5.4% 2.78× <0.001
5 242 4 13% 1.64 0.62 0.94 1.22 9.6% 6.5% 11.8% 10.4% 10.0% 2.65× <0.001
eIF4A-like helicase [PDB:PFB0445c]
[Genbank:AAC71878]
52.6 5.7 1 233 4 15% 0.99 1.05 1.24 1.22 7.9% 8.8% 15.7% 7.4% 8.3% 1.25× 0.024
2 368 7 26% 1.02 1.06 1.18 1.13 7.8% 4.2% 7.6% 7.3% 7.4% 1.16× 0.045
eIF5A [PDB:PFL0210c]
[Genbank:AAN36131]
17.8 5.4 1 117 2 27% 0.12 0.32 1.26 1.79 18.2% 18.1% 10.9% 23.4% 18.2% 15.09× <0.001
2 129 2 16% 1.05 0.98 0.79 0.55 4.9% 12.3% 30.1% 28.8% 20.5% 1.9× 0.005
3 151 2 16% 1.27 1.44 1.09 0.65 19.4% 24.0% 16.9% 21.6% 20.5% 2.23× <0.001
Enolase [PDB:PF10_0155]
[Genbank:AAN35353]
48.6 6.2 1 344 10 30% 1.10 1.11 1.07 0.88 4.2% 4.4% 4.6% 7.2% 4.5% 1.26× <0.001
2 513 10 33% 1.15 1.18 0.99 0.83 14.1% 9.5% 4.8% 10.0% 9.8% 1.42× <0.001h
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3 627 10 33% 1.18 1.17 1.09 0.87 5.4% 5.0% 7.9% 8.5% 6.7% 1.35× <0.001
4 897 10 39% 1.13 1.06 1.11 0.92 11.7% 2.2% 8.3% 5.2% 6.7% 1.22× 0.016
5 138 4 15% 1.03 0.91 1.14 0.93 19.9% 7.8% 9.9% 11.9% 10.9% 1.25× 0.125
3a 213 5 14% 1.83 1.09 0.68 0.52 12.7% 12.9% 24.3% 3.3% 12.8% 3.52× <0.001
4a 122 3 11% 1.43 1.06 0.85 0.73 0.9% 3.1% 16.0% 4.8% 4.0% 1.94× <0.001
EXP-2 [PDB:PF14_0678]
[Genbank:AAN37291]
33.6 5.1 - 133 3 12% 0.27 0.70 0.88 0.97 8.1% 4.3% 10.4% 9.3% 8.7% 3.62× <0.001
HSP40 [PDB:PFE0055c]
[PDB:MAL5P1.12]
[Genbank:CAD51377]
47.8 8.1 - 118 4 19% 0.70 0.85 0.94 2.06 13.2% 37.4% 14.2% 18.9% 16.5% 2.94× <0.001
HSP60 [PDB:PF10_0153]
[Genbank:AAN35351]
62.9 6.7 1 171 5 11% 1.29 0.96 1.10 1.37 8.6% 4.1% 7.0% 3.8% 5.5% 1.43× <0.001
2 235 5 11% 1.31 0.89 1.08 1.35 5.9% 3.8% 5.5% 6.5% 5.7% 1.51× <0.001
HSP70-1a [PDB:PF08_0054]
[Genbank:CAD51185]
74.4 5.5 1 607 10 20% 1.31 1.13 1.01 0.93 14.7% 10.1% 12.9% 7.9% 11.5% 1.41× 0.008
2 644 10 22% 1.46 1.23 1.06 0.96 5.7% 4.5% 10.8% 7.1% 6.4% 1.52× <0.001
HSP70-2a [PDB:PFI0875w]
[Genbank:CAD51861]
72.5 5.2 1 486 8 17% 0.95 1.15 0.98 1.08 8.7% 5.0% 7.8% 8.1% 8.0% 1.2× 0.014
2 724 10 23% 1.06 1.07 1.02 1.11 8.6% 4.8% 7.2% 4.4% 6.0% 1.08× 0.369
3 694 10 21% 1.26 0.87 1.03 1.09 4.9% 2.5% 6.1% 4.1% 4.5% 1.46× <0.001
HSP70-3a [PDB:PF11_0351]
[Genbank:AAN35935]
73.7 6.5 1 193 5 7% 1.08 0.97 0.97 1.06 7.2% 7.8% 16.2% 4.9% 7.5% 1.11× 0.299
2 488 8 12% 1.01 0.98 1.16 1.11 8.0% 2.2% 11.3% 6.2% 7.1% 1.19× 0.028
CA1 - [Genbank:NP_001729] 28.9 6.6 1 264 5 32% 1.48 0.98 0.60 0.59 6.2% 4.3% 13.7% 3.8% 5.2% 2.5× <0.001
2 412 7 40% 1.16 0.94 0.72 0.77 6.0% 7.1% 17.4% 6.0% 6.6% 1.61× <0.001
Human SOD1 - [Genbank:NP_000445] 16.2 5.7 - 247 5 57% 1.04 1.18 1.13 0.74 9.2% 12.5% 7.3% 16.2% 10.8% 1.6× 0.001
HETK [PDB:PFF1335c]
[PDB:MAL6P1.153]
[Genbank:CAG25088]
20.6 7.0 - 575 8 56% 1.02 1.13 0.96 0.74 1.9% 9.0% 5.9% 7.5% 6.7% 1.53× <0.001
Table 2 (Continued)
Protein data for the 54 protein isoforms identified in this studyh
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Hypothetical protein PF10_0325 [PDB:PF10_0325]
[Genbank:AAN35522]
33.2 5.6 1 380 7 33% 1.08 1.11 1.04 0.93 1.5% 7.0% 11.7% 14.8% 9.4% 1.2× 0.107
2 497 8 33% 1.13 1.09 0.99 0.88 5.8% 4.9% 18.7% 17.9% 11.9% 1.28× 0.097
Hypothetical protein PFF1295w [PDB:PFF1295w]
[Genbank:CAG25080]
43.9 7.2 - 245 5 20% 1.06 1.04 0.95 0.91 2.2% 7.1% 13.7% 5.0% 6.0% 1.16× 0.072
Hypothetical protein PFI1270w [PDB:PFI1270w]
[Genbank:CAD51940]
24.9 5.5 1 332 6 21% 1.31 0.98 1.01 1.00 11.6% 8.7% 10.1% 14.3% 10.8% 1.34× 0.012
2 74 3 17% 0.93 0.97 1.36 1.65 8.6% 16.8% 11.6% 9.8% 10.7% 1.77× <0.001
M1AP [PDB:MAL13P1.56]
[Genbank:CAD52253]
126.6 7.3 - 171 7 10% 1.47 0.91 0.87 0.89 12.2% 8.7% 13.4% 10.9% 11.5% 1.69× <0.001
OAT [PDB:PFF0435w]
[PDB:MAL6P1.91]
46.0 6.5 - 589 9 29% 1.20 1.05 1.06 1.06 0.9% 5.8% 12.0% 5.4% 5.6% 1.14× 0.116
PEMT [PDB:MAL13P1.214]
[Genbank:CAD52560]
31.3 5.4 1 790 9 46% 1.07 1.12 1.09 0.89 7.2% 10.3% 9.6% 16.7% 9.9% 1.26× 0.049
2 182 3 14% 0.76 0.97 1.13 1.05 6.2% 5.8% 14.0% 16.3% 10.1% 1.49× 0.003
Proteasome component C8 [PDB:PFC0745c]
[Genbank:CAB11152]
29.7 6.4 1 67 1 7% 1.17 1.20 1.12 0.83 12.9% 3.1% 5.1% 7.6% 6.4% 1.44× <0.001
2 275 4 28% 0.98 0.96 0.96 0.82 7.4% 9.2% 10.8% 11.2% 10.0% 1.2× 0.072
TCP1a [PDB:PF11_0331]
[Genbank:AAN35915]
60.6 6.7 - 110 5 11% 1.05 0.97 1.04 1.04 3.0% 4.1% 6.4% 6.2% 5.1% 1.08× 0.190
TPI [PDB:PF14_0378]
[Genbank:AAN36991]
28.1 6.0 1 579 8 43% 1.18 1.13 1.04 0.86 6.1% 4.5% 11.8% 9.4% 7.7% 1.37× <0.001
2 578 8 45% 1.20 1.11 1.07 0.88 7.0% 5.1% 10.0% 9.6% 8.3% 1.37× <0.001
Uridine phosphorylase [PDB:PFE0660c]
[Genbank:CAD51497]
27.5 6.1 - 430 7 35% 1.23 1.16 1.09 0.73 5.2% 3.6% 7.0% 6.5% 5.8% 1.68× <0.001
The average volume ratios represent log2-transformed values and have not been mean-centered around zero. aNomenclature in agreement with Shonhai and coworkers [35]. CA1, human carbonic 
anhydrase 1; eIF, eukaryotic initiation factor; EXP, exported protein; HETK, hydroxyethylthiazol kinase; HSP, heat shock protein; M1AP, M1-family aminopeptidase; OAT, ornithine aminotransferase; 
PEMT, phosphoethanolamine N-methyltransferase; SOD, superoxide dismutase; TCP1a, T-complex protein 1, α subunit; TPI, triose phosphate isomerase.
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data reveal that the expression profiles of some proteins/iso-
forms closely mirror their mRNA levels, for instance for M1-
family aminopeptidase, heat shock protein (HSP)40, and all
but one isoform of actin-I.
Intriguingly, in many other cases the protein expression lev-
els appear to lag behind or to be decoupled from the corre-
sponding mRNA levels (Figure 5). One of the most striking
examples is eIF4A, for which three isoforms (spots 1 to 3)
exhibit an expression peak around TP2/TP3 and are essen-
tially anticorrelated to the corresponding mRNA levels,
whereas two other isoforms of the same protein (spots 4 and
5) exhibit a sharp dip in expression at this time, thus some-
what resembling the changes in mRNA abundance (Figure 5).
Similarly, two isoforms of eIF5A (spots 2 and 3) show a mod-
est decrease in expression during schizont development and
thereby mirror the mRNA levels with a delay, whereas one
isoform with a considerably more acidic isoelectric point
(spot 1) exhibits a 15-fold increase in expression (Figure 5).
Another example is enolase, for which most full-length iso-
forms (spots 1 to 5) show only minor changes in protein abun-
dance, whereas two isoforms that correspond to a lower
molecular mass (spots 6 and 7) are characterized by a gradual
decrease in expression throughout the time course and thus
resemble the corresponding mRNA levels more closely (Fig-
ure 5). Finally, although the expression profiles of four actin-
I isoforms (spots 1 to 4) are almost identical to their mRNA
profiles, one apparently truncated isoform (spot 5; Figure 1)
does exhibit an essentially anticorrelated profile (Figure 5).
These examples illustrate that during the P. falciparum IDC
each protein isoform exhibits a specific abundance profile
that may dramatically differ from the corresponding mRNA
profile and/or from the protein abundance profiles of other
isoforms of the same protein. These findings are consistent
with the notion that different isoforms of a given protein may
serve different biological roles during the IDC of Plasmodium
spp. [10,21].
Western blot analyses
In order to validate the protein spot identifications made by
mass spectrometry and the 2D-DIGE protein abundance
measurements, we conducted Western blot analyses focusing
on two P. falciparum proteins, namely enolase and eIF5A
(Figure 6). Antibodies raised against the full-length P. falci-
parum enolase [37] recognized at least 10 protein spots on
the two-dimensional Western blot (Figure 6a). Seven of these
spots that could be matched on silver-stained gels (spots 1 to
5, 3a, and 4a) were also analyzed by mass spectrometry and
confirmed as enolase (Table 2). The one-dimensional blot
(Figure 6b) revealed that the expression level of both full-
length enolase (about 55 kDa) and of several much fainter
bands at lower molecular weigh t  ( a b o u t  3 5  t o  4 5  k D a )
r e m a i n e d  m o r e  o r  l e s s  c o n s t a n t  t h r o u g h  T P 1  t o  T P 3 ,  a n d
decreased somewhat in TP4, which is in good agreement with
the expression profiles yielded by 2D-DIGE (Figure 5).
For eIF5A, we used antibodies that had originally been raised
against the eIF5A protein from tobacco plants [38] but had
also been used successfully to detect this protein in P. vivax
[39]. These antibodies detected three protein spots on the
two-dimensional Western blot (run with protein from TP3)
that migrate at approximately 18 kDa, which corresponds to
the predicted molecular weight of P. falciparum eIF5A (Fig-
ure 6c, lower panel). All three spots were also excised from sil-
ver-stained two-dimensional gels and identified as P.
falciparum eIF5A by mass spectroscopy (Table 2). Similar to
enolase, we observe a good correlation between the protein
abundance profiles detected by 2D-DIGE and Western blot-
ting. The total protein abundance profile revealed by the one-
dimensional Western blot is characterized by a slight increase
from TP1 to TP2 and the rapid decline through TP3 and TP4
Overview of relative protein abundance dynamics during the P. falciparum  schizont stage Figure 4
Overview of relative protein abundance dynamics during the P. 
falciparum schizont stage. The 278 differential gel electrophoresis 
(DIGE) protein expression profiles that exhibit a statistically significant 
change (analysis of variance [ANOVA] P < 0.01) and a considerable 
maximum fold change (>1.4×) across the P. falciparum schizont 
development were grouped according to the direction of abundance 
change (see Figure 3b) and subsequently subjected to hierarchical 
clustering, with the icons in the upper right corner of each panel providing 
a generic illustration of each category.
(a)
(b)http://genomebiology.com/2008/9/12/R177 Genome Biology 2008,     Volume 9, Issue 12, Article R177       Foth et al. R177.11
Genome Biology 2008, 9:R177
Expression profiles comparing relative mRNA and protein abundance Figure 5
Expression profiles comparing relative mRNA and protein abundance. The panels summarize mRNA and protein abundance data for individual 
P. falciparum genes, with PlasmoDB accession numbers indicated below the gene names. Both the relative mRNA and protein abundance levels determined 
in this study for four schizont-stage time points (TPs) are based on the same parasite samples from a single large-scale in vitro culture and are indicated by 
gray and colored lines (see panel legends), respectively. In addition, the previously published transcript dynamics across the whole intra-erythrocytic life 
cycle [2] are included as black lines, with the black dots representing the corresponding raw data. All abundance profiles were mean-centered around zero 
based on the data points between 34 and 46 hours post-invasion. Asterisks in the panel legends denote cases for which analysis of variance (ANOVA) P < 
0.01 and maximum fold change >1.4×. The insert in the eukaryotic initiation factor (eIF)5A panel depicts actual two-dimensional gel images to provide an 
approximate impression of absolute protein abundance levels between the three eIF5A isoforms.
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(Figure 6d). This pattern mirrors the DIGE expression pro-
files of spots 2 and 3 (Figure 5), whereas the differentially
expressed spot 1 - because of its low absolute expression level
(see inset in Figure 5) - presumably does not contribute sig-
nificantly to the overall changes in protein abundance.
Discussion
Protein expression profiles
2D-DIGE is a powerful quantitative proteomics technique
[32,40] that is commonly employed to study cells or tissues
under two or more experimental conditions, but it is rarely
used to uncover large-scale proteome changes during the nat-
ural development of biological systems (see, for example, ref-
e r e n c e  [ 4 1 ] ) .  I n  t h i s  s t u d y  w e  s h o w  t h a t  2 D - D I G E  i s  w e l l
suited to generate time-course protein expression profiles in
a medium-throughput manner for malaria parasites as they
progress through their IDC.
Previous investigations of large-scale quantitative protein
changes in P. falciparum considered very broadly defined
parasite stages and, in particular, divided the approximately
48-hour IDC into three phases (rings, trophozoites, and sch-
izonts) [10,28,29]. In contrast, the proteome time course
experiment presented here is based on four TP samples taken
at 4-hour time intervals, with the resulting protein expression
profiles revealing proteome changes in schizont-stage para-
sites at the highest temporal resolution ever attempted. Fur-
thermore, although some of the previous studies employed
semiquantitative mass spectrometric measures to quantify
protein abundance [28,29], this report is - to the best of our
knowledge - the first to make use of the exquisitely quantita-
tive 2D-DIGE technology [32,40] in malaria parasites. For
the 623 proteins/isoforms analyzed in this study we gener-
ated a total of more than 9,000 individual protein abundance
measurements (for four TPs and taken in quadruplicate per
spot). The high resolution and reproducibility of this
approach thus allow for in-depth investigation into protein
(isoform) dynamics in the malaria parasite.
The overall biological relevance of the expression profiles is
indicated by the fact that they exhibit trends that one would
plausibly expect to observe in schizont-stage malaria para-
sites. More than half of all protein spots exhibit a statistically
significant change in protein abundance across the four TPs,
which is consistent with the fact that most transcripts show a
wave-like expression pattern during the IDC [2]. Of the 278
proteins that also show a considerable fold change (>1.4×) in
abundance, approximately one-quarter exhibit an expression
peak during schizont development. In particular, closer
examination of the expression profiles of actin-I, a protein
that is part of the molecular motor machinery essential for
erythrocyte invasion (which occurs between schizont and ring
stages) and whose expression is expected to be significantly
upregulated in schizonts [42], confirms a significant increase
in DIGE-measured expression from TP1 to TP3 (Figure 5).
Comparing transcript and protein abundance
The direct comparisons of relative levels of transcript and
protein expression, both determined from the same parasite
preparations, yielded valuable insights into their different
possible correlations. In many cases we find that changes in
transcript levels are clearly mirrored by corresponding
changes in protein abundance, for example in HSP40 and
most isoforms of actin-I (see Figure 5). In both cases tran-
script and protein levels increase, suggesting that here an
increased number of transcripts leads directly to a higher vol-
ume of translation and protein abundance.
In many other instances, though, changes in mRNA and pro-
tein levels are less well correlated, which may reflect
sequence-specific factors and post-transcriptional regulation
affecting both protein synthesis and/or degradation [43,44].
In yeast, translation rates vary greatly between transcripts,
and the underlying molecular mechanisms probably include
codon usage, transcript length, saturation effects, ribosomal
occupancy, and translational suppression [45-48]. On the
other hand, the major pathway of targeted protein degrada-
tion - ubiquitin-mediated proteasome activity - has already
been shown to be present in P. falciparum, to be developmen-
tally regulated, and to be essential for intra-erythrocytic
Immunoblot analysis of enolase and eIF5A in P. falciparum schizont-stage  parasites Figure 6
Immunoblot analysis of enolase and eIF5A in P. falciparum 
schizont-stage parasites. (a) Two-dimensional Western blot of 
enolase. (b) One-dimensional Western blot of enolase. (c) Two-
dimensional Western blot of eukaryotic initiation factor 5A (eIF5A). The 
upper panel shows the blotted nitrocellulose membrane after staining with 
a reversible protein dye (MemCode; Pierce), whereas the lower panel 
depicts the resulting immunoblot after detection with antibodies raised 
against a plant eIF5A. (d) One-dimensional Western blot of eIF5A. For 
each two-dimensional blot, 500 μg parasite protein (time point [TP]3, 42 
hours post-invasion) was separated on a 13 cm isoelectric focusing (IEF) 
strip pH 4 to 7 (GE Healthcare) followed by an 11% polyacrylamide gel. 
Protein spots that could be matched on silver-stained gels were confirmed 
as P. falciparum enolase (panel a) and eIF5A (panel c) by tandem mass 
spectrometry and are indicated by arrowheads. For the one-dimensional 
blots, each lane was loaded with 10 μg parasite protein from the 
corresponding time point sample. eIF, eukaryotic initiation factor.
(a)
(b)
(c)
(d)http://genomebiology.com/2008/9/12/R177 Genome Biology 2008,     Volume 9, Issue 12, Article R177       Foth et al. R177.13
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development [26,49-51]. We find that for some proteins
changes in protein abundance parallel changes in transcript
levels after a delay; examples include isoforms 2 and 3 of
eIF5A, adenosine deaminase, hydroxyethylthiazole kinase,
proteasome component C8, and uridine phosphorylase (see
Figure 5 and Additional data file 2). In these examples the
transcript and protein levels both decrease, and the time
delay could be explained by an initially low protein turnover
rate. As soon as the transcript levels drop and corresponding
protein translation decreases, the proteins already present in
the cell remain stable for some time before being degraded.
Alternatively, it could also be that the maximum translation
rate for a given protein is already reached at a less-than-max-
imum transcript concentration, with the translation rate
dropping only once the transcript level falls below a certain
threshold. Other cases show a decrease in transcript levels but
apparently no corresponding change in protein abundance;
examples include HSP70-2 or ornithine aminotransferase
(see Figure 5 and Additional data file 2). These observations
could be accounted for by the same explanations given for the
cases of delayed degradation, except that here the proteins
may be even more resistant to degradation and/or their tran-
script levels may have a still lower threshold at which transla-
tion already occurs at a maximum rate. In the case of greater
resistance to protein degradation, one would expect to
observe a drop also in protein abundance after some more
time if transcript levels remained low. Similarly, for both T-
complex protein 1 subunit α and EXP-2 (Additional data file
2) the microarray data suggest a sudden, approximately two-
fold reduction in transcript levels that is not mirrored in the
concomitant protein abundance profiles. Apart from the pos-
sible explanations mentioned above, here the apparently
short duration of these transcript level changes might be
'smoothed out' by the potentially more slowly reacting pro-
tein abundance.
In contrast, the abundance profiles for a number of proteins/
isoforms (M1-family aminopeptidase, HSP70-1, hydrox-
yethylthiazole kinase, proteasome component C8, triose
phosphate isomerase, and uridine phosphorylase; see Figure
5 and Additional data file 2) show transcript level increases
toward the end of the time course that are not registered in
the protein abundance measurements. This may indicate a
simple lag between transcript and protein synthesis or some
more specific translational repression [7,9]. It was shown
previously that Plasmodium parasites can produce and 'store'
transcripts in preparation for translation at a more appropri-
ate, later time in the life cycle [7].
Even more surprising are the protein abundance profiles
recorded for HSP60 (Additional data file 2). Although the
transcript level exhibits a sustained decrease by approxi-
mately twofold, protein abundance increases. Possible expla-
nations for this finding include the following: translational
repression of the transcripts whose diminishing inhibitory
activity later coincides with lower transcript levels; significant
changes in protein turnover; and the presence of other
HSP60 isoforms with different PTMs (see below) that have
yet to be identified on the gel and are therefore not included
in our analysis. Such additional isoforms could in fact make
up the bulk of this protein in the cell, in which case the appar-
ent protein abundance increase observed for the isoforms
that we have identified as HSP60 would be due to an inter-
conversion from other HSP60 isoforms.
Protein isoforms and PTMs
One of the most striking results of this study is the insight into
the abundance and regulation of Plasmodium protein iso-
forms. It is evident that many proteins occur in vivo in more
than one isoform because of pretranslational events such as
alternative splicing or transcription initiation/termination
and because of PTMs such as phosphorylation, acetylation,
ubiquitination, cysteine oxidation, and protein cleavage (see,
for example, reference [33]). Most such modifications and
shifts from one isoform to another are invisible to common
transcript analyses as well as many conventional proteomics
analyses. Thus, at the present time, very little is known about
their role in the Plasmodium life cycle.
In this study we identified five protein isoforms that corre-
spond to the P. falciparum eIF4A, an RNA helicase with
probable function in translation initiation that is essential for
growth [34]. Three of these isoforms exhibit a protein expres-
sion pattern that is almost perfectly anticorrelated to that of
two other isoforms corresponding to the same protein. It may
be that the observed patterns correspond, at least in part, to
the direct interconversion of protein isoforms 4 and 5 into
isoforms 1 to 3, and back again. The nature of the PTMs giving
rise to these five isoforms of eIF4A in P. falciparum has not
been investigated, but the lateral shift on two-dimensional
gels is consistent with phosphorylation of this protein, a mod-
ification previously observed in plants and yeast [52-55]. In
plants the eIF4A phosphorylation state has been observed to
change after diverse stimuli such as heat shock, hypoxia, and
pollen tube germination, whereas in the Plasmodium-related
parasite Toxoplasma gondii eIF4A shows strict stage-specific
expression regulated at the transcriptional level [56]. Fur-
thermore, in Drosophila eIF4A has been shown to regulate
directly the ubiquitin-mediated degradation of a transcrip-
tional regulator [57]. Whether the P. falciparum eIF4A exerts
its influence at the level of protein translation initiation and/
or whether it has an effect on the expression of other proteins
by affecting ubiquitin-mediated degradation remains to be
elucidated. Either way, the fact that its transcript levels cycle
throughout the IDC [2] (Figure 5) and that its protein isoform
states change during schizont development is consistent with
an involvement in controlling developmentally regulated pro-
tein expression in this parasite.
Actin-I was also identified as five isoforms in this study. One
of these (spot 5, Figure 1) appears truncated, considerably
shifted toward a more alkaline pI, and it exhibits a drasticallyhttp://genomebiology.com/2008/9/12/R177 Genome Biology 2008,     Volume 9, Issue 12, Article R177       Foth et al. R177.14
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different expression profile compared with the other four iso-
forms (Figure 5). Their parallel arrangement on the gel (Fig-
ure 1) is consistent with these isoforms differing in their
phosphorylation status, although we note that phosphoryla-
tion of actin has been observed in mammals, plants, and slime
molds [58-62]. Similarly, we show the glycolytic enzyme eno-
lase to be present in at least seven isoforms (Figure 6a),
including two truncated versions (spots 3a and 4a) that
apparently lack their amino-terminus, as judged by the pep-
tide coverage revealed during the mass spectrometric analysis
(data not shown). Whether the shortened isoforms of actin
and enolase represent mere degradation byproducts or actu-
ally serve specific functions is an interesting open question. It
is currently also unknown whether they originate from prote-
olytic cleavage or alternative pretranslational events. In P.
yoelii some PTMs of enolase have been shown to be due to
phosphorylation, with different isoforms being localized in
different cellular compartments [21]. In the related parasite
T. gondii two isoenzymes (encoded by two separate genes)
show substantial localization in the nucleus and are
expressed in a stage-specific manner [63]. Enolase has been
reported to serve a number of functions unrelated to glycoly-
sis in various organisms (see, for example, the references list
in the report by Ferguson and coworkers [63]), and in the
Apicomplexa it has been suggested to be involved in host cell
invasion by Plasmodium and Eimeria and in the regulation of
stage-specific gene transcription in Toxoplasma  [63-65].
Interestingly, aldolase - another glycolytic enzyme - was pre-
viously shown to be part of the molecular invasion machinery
of apicomplexan parasites [66]. Its possible involvement, in
host cell invasion and gene regulation, its high absolute
expression level (the enolase protein spots are among the
most intense on silver stained two-dimensional gels), and its
multiple protein isoforms therefore make enolase a highly
intriguing protein that clearly merits further study.
Conclusion
Our direct comparisons of relative transcript and protein
abundance levels uncover a dynamic and complex picture of
stage-specific gene and protein expression in P. falciparum.
Particularly revealing are the insights into differentially
expressed isoforms of some proteins that offer a glimpse of an
almost bewildering complexity that may lie beneath corre-
sponding RNA profiles and a deceptively simple appearance
of overall protein abundance. Many of these isoform changes
are fundamentally undetectable in transcript-level analyses
and are invisible even to common protein-level investigations
such as Western blotting and conventional high-throughput
proteomics based on mass spectrometry. Our data reveal sig-
nificant and distinct isoform changes for several proteins (for
example, eIF4A, eIF5A, and HSP70-2) as the malaria para-
sites progress through the late stage of their intra-erythro-
cytic life cycle. The high reproducibility and temporal
specificity of our observations strongly suggest that these
changes are more than inconsequential fluctuations and that
they represent biologically significant modifications. It is
likely that many of these isoforms lead to different biological
functionality of the cognate protein.
In the future, extending DIGE-based proteome profiling
beyond the 12-hour schizont-stage window analyzed here to
cover the entire intra-erythrocytic life cycle of P. falciparum
(and also beyond the pH 3 to pH 7 isoelectric focusing [IEF]
range) will lay the foundation for the proteomic exploration of
the parasites' response to inhibitors or the differences
between diverse strains from time course and protein isoform
oriented perspectives.
Materials and methods
Cell culture and parasite sampling
P. falciparum parasites were initially grown in flasks under
standard conditions [67]. In short, washed human red blood
cells (RBCs) were kept at 2% parasitemia in RPMI 1640
medium, including 25 mmol/l HEPES (GIBCO, Life Technol-
ogies, San Diego, CA, USA) supplemented with 0.25% Albu-
MAX II (GIBCO), 2 g/l sodium bicarbonate (Sigma, St. Louis,
MO, USA), 0.1 mmol/l hypoxanthine (Sigma), and 10 mg/l
gentamycin (GIBCO), at 37°C, 5% carbon dioxide, and 3%
oxygen. Parasites were synchronized by sorbitol treatments
(5% sorbitol for 10 minutes at room temperature) over several
generations at 5 hours and/or 20 hours after the start of RBC
invasion. A tightly synchronized culture was transferred at
the beginning of RBC invasion to a Labfors bioreactor (Infors,
Bottmingen, Switzerland). After 5 hours of invasion at 14.7%
hematocrit in 'bioreactor medium' (containing a total of 0.5%
AlbuMAX II and 37.5 mmol/l HEPES at pH 7.4), the culture
was diluted to 1% hemotacrit. After intra-erythrocytic growth
over 42 hours, including regular medium replacement, a sec-
ond round of RBC invasion at high hematocrit was allowed to
take place over 6 hours. The correct progression of the result-
ing culture was monitored every 2 hours for a total of 50
hours, and TP samples corresponding to 34, 38, 42, and 46
HPI were collected for further analysis. Parasitized RBCs
were washed with phosphate-buffered saline (PBS) and lysed
in 0.1% saponin (weight/vol in PBS) over 5 minutes at room
temperature. Parasites were thoroughly washed with chilled
PBS, pelleted, snap-frozen in liquid nitrogen, and stored at -
80°C.
Protein preparations
Lysis buffer (30 mmol/l Tris, 8 mol/l urea, 2 mol/l thiourea,
and 4% CHAPS [pH 8.0] at room temperature) was added to
the frozen parasite pellets, and the cells were disrupted by
three cycles of freezing/thawing followed by sonication on ice
over 10 minutes at 25% amplitude (with pulses of 2 seconds
on, 3 seconds off, resulting in 4 minutes total pulse-on time).
Insoluble material was pelleted for 30 minutes at 16,100 g at
4°C, followed by ultracentrifugation for 30 minutes at
approximately 100,000 g  at 4°C (TLA-120.1 rotor in an
Optima Max ultracentrifuge; Beckman Coulter, Fullerton,http://genomebiology.com/2008/9/12/R177 Genome Biology 2008,     Volume 9, Issue 12, Article R177       Foth et al. R177.15
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CA, USA). Proteins in the cleared lysate were purified by chlo-
roform/methanol precipitation, the pellet air dried, and the
precipitated proteins resuspended in lysis buffer. Protein
concentrations for all protein preparations were determined
using the 2D-Quant Kit from Amersham (GE Healthcare Bio-
Sciences AB, Uppsala, Sweden).
DIGE labeling
For CyDye (GE Healthcare) minimal labeling, an aliquot of
each protein preparation was divided into two parts, of which
one half was labeled with Cy3 and the other half with Cy5
DIGE Minimal Dye Fluors (GE Healthcare; dissolved in anhy-
drous N,N-dimethyl-formamide) on ice for 30 minutes in the
dark, using 0.4 nmol CyDye per 50 μg protein. A protein ref-
erence pool/internal standard consisting of equal amounts of
the four TP samples was similarly labeled with Cy2. All labe-
ling reactions were stopped by addition of 1 μl 10 mmol/l
lysine per 0.4 nmol CyDye.
Two-dimensional gels: first dimension
The first dimension of the protein separation (IEF) was per-
formed using Immobiline DryStrips (GE Healthcare). For
DIGE analysis 24 cm strips (pH3-7NL, nonlinear pH gradi-
ent) were loaded with 50 μg protein per CyDye (a total of 150
μg protein per strip) during rehydration, whereas for prepar-
ative silver-stained gels each 24 cm strip was loaded with 500
μg protein. To each protein sample to be loaded on a strip,
immobilized pH gradient (IPG) buffer (pH 4 to 7; GE Health-
care) was added to a final concentration of 0.5%, and the total
v o l u m e  o f  t h e  s a m p l e  w a s  a d j u s t e d  t o  4 5 0  μl by adding
DeStreak Solution (GE Healthcare). Rehydration was carried
out overnight in strip holders (GE Healthcare) placed in the
Ettan IPGphor 3 instrument (GE Healthcare); a low voltage
(30 V) was applied during the last 7 hours. IEF was typically
carried out in the Ettan IPGphor 3 by ramping from 30 V to 1
kV over 1 kV hour (kVh), holding at 1 kV for 2 kVh, ramping
from 1 kV to 8 kV over 13.5 kVh, and holding at 8 kV for 52
kVh, yielding a total of about 69 kVh.
For two-dimensional Western blots, IEF was carried out
using 13 cm Immobiline DryStrips (pH 4 to 7) as described
above but with the following modifications: each strip was
loaded by rehydration with 500 μg protein in a total volume
of 250 μl, and the IEF protocol consisted of ramping from 30
V to 1 kV over 1 kVh, ramping from 1 kV to 8 kV over 11.25
kVh, and holding at 8 kV for 12 kVh, yielding a total of about
24 kVh.
Two-dimensional gels: second dimension
IPG strips were equilibrated under constant agitation at room
temperature in the dark, first for 15 minutes in equilibration
buffer (75 mmol/l Tris [pH 8.8], 6 mol/l urea, 30% glycerol,
2% SDS) supplemented with 1% (weight/vol) DTT (dithioth-
reitol), followed by 15 minutes in equilibration buffer supple-
mented with 2.5% (weight/vol) iodoacetamide. Strips were
briefly washed in 1% SDS, placed atop an 11% polyacrylamide
gel (25.5 × 20 cm), and overlayed with about 2 ml of a melted
agarose solution (1× running buffer, 0.5% to 1% agarose,
bromophenol blue). Second-dimension protein separation
was achieved by running the gels in SDS buffer in an Ettan
Daltsix Electrophoresis System (GE Healthcare). For 2D-
DIGE using 24 cm IEF strips, proteins were run until the dye-
front reached the bottom of the gel, whereas for two-dimen-
sional Western blots using 13 cm IEF strips, the dye front was
run only about 10 cm into the gel.
DIGE data acquisition
Gels with CyDye-labeled samples were scanned on a Typhoon
Trio scanner (GE Healthcare) at 100 μm resolution. The Cy3
channel was scanned with medium and the other two chan-
nels with normal sensitivity. The scanned images were
cropped and imported into DeCyder 2D software, version 6.5
(GE Healthcare). After spot detection in the DIA module (dif-
ferential in-gel analysis), spots were automatically matched
across gels in the BVA (biological variation analysis) module.
Spot assignments across all gels were then manually
inspected, and where necessary spots were either re-matched
or excluded from the subsequent analysis.
DIGE data analysis
To arrive at relative protein abundance measurements using
2D-DIGE, we used the DeCyder 2D software, which first cal-
culates the raw background-subtracted volume for each spot
on a gel, which corresponds to the volume underneath its
three-dimensional representation (see Figure 2a). Spot vol-
umes observed in the Cy3 and Cy5 channels were normalized
against the corresponding spot volumes observed in the Cy2
channel. To do so, two normalization factors are determined
(one for the comparison Cy3/Cy2, and one for Cy5/Cy2), and
all spot volumes observed in these channels (Cy3 or Cy5) are
multiplied by the corresponding normalization factor.
The 'normalized volume ratio' values and one-way ANOVA P
values were exported from DeCyder. For a given spot, the
'normalized volume ratio' refers to the ratio of the normalized
spot volume observed in the Cy3 or Cy5 channel divided by
the spot volume of this spot measured in the Cy2 channel,
with Cy2 having been used exclusively to label the protein ref-
erence pool. By default, DeCyder annotates these volume
ratios such that an x-fold increase and decrease in protein
abundance is denoted by +x and -x, respectively (for instance,
a 2-fold decrease being represented by -2). Thus, to calculate
the standard deviation for the protein abundance values (vol-
ume ratios) for a given protein spot and TP (determined from
four gels), the volume ratios were transformed such that an x-
fold decrease in protein abundance is represented by 1/x (for
example, a 2-fold decrease being represented by 0.5). The
'relative standard deviation' for each protein spot and TP was
determined by dividing the standard deviation of its protein
abundance values (volume ratios) by the arithmetic mean of
those same values. The median of the four individual relative
standard deviations across the four TP measurements washttp://genomebiology.com/2008/9/12/R177 Genome Biology 2008,     Volume 9, Issue 12, Article R177       Foth et al. R177.16
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then taken as a measure of experimental reproducibility for a
protein spot.
Finally, the volume ratios were log2 transformed such that an
x-fold increase and decrease in protein abundance is denoted
by +log2(x) and -log2(x), respectively (for example, a 2-fold
decrease being represented by -1). For a given protein spot
and TP, such log2-transformed volume ratios were deter-
mined from four gels, and averaging these values yielded that
protein spot's average protein abundance at that TP. The
averaged protein abundance values for all four TPs were then
used to construct the abundance profile for that protein.
To classify the direction of change ('up', 'up-down', and so on)
for protein expression profiles that showed significant change
(ANOVA P < 0.01 and fold change >1.4×; see Figure 3b), we
carried out pair-wise comparisons of abundance measure-
ments (not log-transformed values) from neighbouring TP
samples. To smooth the classification and disregard very
small changes between neighbouring time point samples TPn
and TPn+1, we only considered changes for which Absolute-
Value(Abundance [TPn] - Abundance [TPn+1])/Aver-
age(Abundance [TPn]; Abundance [TPn+1]) > 12.5%.
Silver staining
Gels were fixed in a solution of 40% ethanol and 10% acetic
acid, washed, and sensitized in 30% ethanol, 6.8% sodium
acetate, and 0.2% sodium thiosulfate. After further washing,
the gels were incubated in 0.25% silver nitrate for 15 to 20
minutes, washed, and developed in 2.5% sodium carbonate
and 0.015% formaldehyde. The staining reaction was stopped
in 1.5% Na2-EDTA.
Two-dimensional gel spot identification by MS/MS
Protein spots were excised from preparative gels and
destained in 15 mmol/l K3Fe(CN)6 and 50 mmol/l Na2S2O3,
followed by washes in 100 mmol/l NH4HCO3, in 50 mmol/l
NH4HCO3 in 50% (vol/vol) acetonitrile, and in acetonitrile.
The destained gel pieces were dried in a vacuum centrifuge
and digested overnight at 37°C in 12.5 ng/μl mass-spec grade
trypsin Gold (Promega, Madison, WI, USA) in 50 mmol/l
NH4HCO3. After collection of the supernatant, the digested
peptides were further extracted from the gel with 20 mmol/l
NH4HCO3 and with 5% formic acid/50% acetonitrile. The
combined supernatants were purified and concentrated in
0.5% formic acid/acetonitrile and in acetonitrile using Zip-
Tips (Millipore, Billerica, MA, USA). The peptides were resus-
pended in 0.1% (vol/vol) trifluoroacetic acid in 50%
acetonitrile and spotted on a MALDI target plate together
with matrix solution (saturated solution of a-cyano-4-
hydroxycinnamic acid [CHCA] in 0.1% trifluoroacetic acid/
50% acetonitrile). Peptide mass fingerprints and MS/MS
fragment ion masses were generated by MALDI-TOF-TOF
mass spectrometry (Matrix-Assisted Laser Desorption/Ioni-
zation Time-Of-Flight tandem mass spectrometry) at the pro-
teomics core centers of Nanyang Technological University
and the National University of Singapore. The peptide and
ion masses were then used to query both general (GenBank
nonredundant) as well as custom-made protein databases
(including both Plasmodium sequences from PlasmoDB-5.3
[68] and human proteins) using Mascot Server software, ver-
sion 2.2.01 (Matrix Science, London, UK). Search parameters
were set as follows: enzyme specificity set to trypsin, allowing
up to one missed cleavage, fixed modification to carbamid-
omethyl (C), variable modification to oxidation (M), peptide
tolerance to ± 100 ppm, and MS/MS tolerance to ± 1 Da.
Western blots
For one-dimensional Western blots, 10 μg protein were
loaded per lane and separated on approximately 10 cm × 7 cm
SDS-PAGE gels, whereas for two-dimensional blots 500 μg
protein were loaded per IEF strip/gel (see above). PAGE-sep-
arated proteins were transferred to nitrocellulose membranes
and visualized using the MemCode Reversible Protein Stain
Kit (Pierce/Thermo Fisher Scientific, Waltham, MA, USA).
The membranes were blocked for 1 to 1.5 hours in 3% to 4%
skim milk powder (BioRad, Hercules, CA, USA) and 0.5% to
1% Tween20 in Tris-buffered saline (blocking buffer). Pro-
teins were detected using antibodies (see Acknowledgements,
below) at 1:500 to 1:2,000 dilutions in blocking buffer. Sec-
ondary antibodies conjugated to horseradish peroxidase (GE
Healthcare) were employed at 1:2,000 to 1:4,000 dilutions
and visualized using SuperSignal chemiluminescent sub-
strates (Pierce) or ECL kit (GE Healthcare) and X-ray film
(Kodak).
Microarray analysis
Relative RNA abundance levels were determined based on a
set of saponin-lysed parasite pellets identical to those used for
protein analysis by 2D-DIGE. RNA extraction, cDNA synthe-
sis and labeling, as well as microarray hybridizations of the
four samples representing time points 1, 2, 3, and 4 against a
reference RNA pool were carried out as described previously
[2]. Hybridizations were performed for 16 hours at 65°C using
a Maui hybridization system (BioMicro Systems, Salt Lake
City, UT, USA). Microarray data were aquired with GenePix
Pro 6.0 software (Axon Instruments, Union City, CA, USA),
and Lowess normalization and subsequent filtering for qual-
ity control were carried out using Acuity 4.0 (Axon Instru-
ments). Spots were considered to be of good quality when
they were unflagged and had a median intensity greater than
the local background plus 2 times the standard deviation of
the background for each dye channel. The complete microar-
ray data are available at the Gene Expression Omnibus data-
base at the National Center for Biotechnology Information
[GEO:GSE13251].
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